Significance, prognostic value and management of heart rate in hypertension
Related Experiment Video
Updated: May 3, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Pierre-Yves Courand1, Pierre Lantelme1
1Cardiology Department, European Society of Hypertension Excellence Centre, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France; Génomique Fonctionnelle de l'Hypertension Artérielle, EA 4173, Université Claude-Bernard Lyon-1, Villeurbanne, France; Hôpital Nord-Ouest, Villefranche-sur-Saône, France.
Insights
Elevated resting heart rate in hypertension may indicate higher cardiovascular risk but isn't a proven modifiable risk factor. Current evidence suggests it's more a marker than a target for intervention in these patients.
Area of Science:
- Cardiology
- Hypertension Research
- Epidemiology
Background:
- Resting heart rate (RHR) is a known risk marker and factor in coronary artery disease and heart failure.
- Its role in hypertensive individuals without overt cardiac disease is less understood.
- High RHR in hypertension is linked to increased mortality risk in some studies.
Purpose of the Study:
- To review the pathophysiological effects of heart rate.
- To evaluate the prognostic value of heart rate in hypertensive patients.
- To discuss the management of heart rate in this population.
Main Methods:
- Review of epidemiological studies and clinical trials.
- Analysis of ambulatory heart rate data.
- Examination of pathophysiological mechanisms linking heart rate to cardiovascular health.
Main Results:
- Elevated RHR in hypertensive patients without cardiac disease appears to be primarily a risk marker, not a modifiable risk factor.
- Intervention trials targeting heart rate reduction have not shown clear benefits in this group.
- Ambulatory and nighttime heart rate may correlate better with cardiovascular outcomes.
Conclusions:
- While high RHR indicates risk, current data do not support targeting heart rate for intervention in hypertensive patients without overt cardiac disease.
- Further research is needed to clarify the role of heart rate management in hypertension.
Abstract:
Many epidemiological studies have demonstrated that resting heart rate is a risk marker but also a risk factor in patients with coronary artery disease and heart failure. In hypertensive subjects free from overt cardiac disease, the question has been less frequently addressed. A few cohort studies have shown that hypertensive patients with a high resting heart rate have an increased risk of all-cause and cardiovascular death. However, intervention trials have not demonstrated that lowering the heart rate is beneficial in hypertensive subjects. Studies with an assessment of ambulatory heart rate tend to demonstrate a better association between cardiovascular outcomes and variables, including nighttime heart rate. Clinical trials comparing beta-blockers with non-slowing antihypertensive drugs have not demonstrated the superiority of the former. Finally, an elevated resting heart rate in hypertensive subjects free from overt cardiac disease seems to be more a risk marker than a risk factor. Although these patients are at high risk, no scientific data exist to support targeting heart rate. In this review, we describe the pathophysiological effects of heart rate, including vascular cell signalling, link with sympathetic activity and influence on central blood pressure, and the prognostic value and management of HR in hypertensive patients free from overt cardiac diseases.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
